Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
CENTENE CORPORATION

2. Address

Address1
1150 CONNECTICUT AVENUE, NW
 Address2
​SUITE 1000
City
WASHINGTON
 State
DC
 Zip Code
20036
 Country
USA

3. Principal place of business (if different than line 2)

City
​St. Louis
 State
​MO
 Zip Code
​63105
 Country
​USA
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Joseph Musker
​2022238010
​jmusker@centene.com
5. Senate ID#
​306578-12
7. Client Name Self Check if client is a state or local government or instrumentality
​CENTENE CORPORATION
6. House ID#
​386040000
TYPE OF REPORT 8. Year
​2020
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​910,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Joseph Musker
 Date
1/21/2021 9:00:19 AM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 133, Consolidated Appropriations Act of 2021, including provisions relating to No Surprises Act, COVID-19 provisions (FMAP), health extenders (Money Follows the Person, Medicaid spousal impoverishment protections, IAH), prescription drug issues, and PBMs
H.R. 925, The Heroes Act, including provisions related to House Amendment to the Senate Amendments updated Heroes Act; specifically provisions related to provisions related to access to healthcare including FMAP, testing, protections for public health workers, and benefits to children and families impacted by the coronavirus, Federal Medical Assistance Percentages (FMAP)
H.R. 2328, Community Health Investment, Modernization, and Excellence Act of 2019, including provisions relating to Title IV surprise billing provisions
H.R. 3630, No Surprises Act
H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, including provisions relating to Marketplace, Commercial market issues
S. 1895, Lower Health Care Costs Act, including issues relating to surprise billing, prescription drug costs, transparency, interoperability
S. 3013, Encouraging Innovative Benefit Design to Lower Costs for Seniors Act, including provisions relating to prescription drug plans under Medicare Part D (allows for additional drug plan offerings)

Potential legislation titled Health, Education Assistance, Liability Protections, Schools Act (HEALS Act) including provisions relating to commercial market and surprise billing

Issues related to,
ACA marketplace stabilization



17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Joseph
Musker
​
​
John
Kaelin
​
​
Sohini
Gupta
​
​
Danny
Ly
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 133, Consolidated Appropriations Act of 2021, including provisions relating to the No Surprises Act, COVID-19 provisions (FMAP) and health extenders (Money Follows the Person, Medicaid spousal impoverishment protections, IAH)
H.R. 925, The Heroes Act, including provisions related to House Amendment to the Senate Amendments updated Heroes Act; specifically provisions related to provisions related to access to healthcare including FMAP, testing, protections for public health workers, and benefits to children and families impacted by the coronavirus, Federal Medical Assistance Percentages (FMAP)
H.R. 3644/S. 1202, Independence at Home Act of 2019, including provisions relating to improve and provide for a permanent Independence at Home medical practice program under the Medicare program
H.R. 4996, Helping Medicaid Offer Maternity Services (MOMS) Act
H.R. 7659/S. 4840, Ensuring Parity in MA for Audio-Only Telehealth Act of 2020, including provisions relating to (MA audio-only visits are currently not included in risk adjustment calculations
H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act including provisions relating to Medicaid, Medicare issues
H.R. 8337, Continuing Appropriations Act, 2021 and Other Extensions Act, including provisions included in the section titled, Money Follows the Person, Medicaid Spousal Impoverishment Protections
H.R. 8834, Independence at Home Demonstration Improvement Act of 2020, including provisions relating to title XVII of the Social Security Act to extend and improve the Independence at Home Medical Practice Demonstration Program under the Medicare program

S. 3013, Encouraging Innovative Benefit Design to Lower Costs for Seniors Act, including provisions relating to prescription drug plans under Medicare Part D (allows for additional drug plan offerings)

Potential legislation titled Health, Education Assistance, Liability Protections, Schools Act (HEALS Act) including provisions relating to Medicaid Medicare issues

Issues relating to,
Medicaid Fiscal Accountability Regulation;
Medicare Part D Issues;
Medicare Advantage



17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Joseph
Musker
​
​
John
Kaelin
​
​
Sohini
Gupta
​
​
Danny
Ly
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)